SoftgenomicsSoftgenomics

R&D

The R&D center is creating the future through innovative researches.

Softgenomics’ molecular diagnosis research institute consists of the Research Planning Team which conducts new research and the possibility of commercialization based on new technologies; the Molecular Diagnosis Research Team which develops high-performance diagnostic reagents; the Medical Device Development Team which conducts the design and development of biochips and conducts R&D on diagnostic devices and sensors; and the Bio Information Analysis Team which analyzes DNA and its variants and develops in silico diagnostic design. Each team is conducting research to develop diagnostic products of the highest quality by combining specialized technologies through systematic collaboration.

R&D Planning
Division

Molecular Diagnostics
Division

Medical Device
Division

Bioinformatics
Division

R&D Planning Division

  • 01

    Research and Development of Diagnostic Product

    This team continuously reviews and plans research on the applicability of diagnostic product development and the possibility of additionally developing technologies by constantly exploring new technologies.

  • 02

    Supervising R&D projects

    The team supervises R&D projects and makes sure they become successful projects, and supports the securing of accumulated technologies and intellectual property rights.

Molecular Diagnostics Division

  • 01

    Direct nucleic acid extraction research

    The team is testing the optimum solution for easily and rapidly extracting highly pure nucleic acid from various specimens and samples extracted based on nucleic acid high enrichment technology our company has, and is applying this technology to biochips.

  • 02

    Highly specific nucleic acid amplification research

    This team is researching the reaction condition showing optimum accuracy and simultaneous reaction conditions on a large number of primers through the balance between sensitivity and specificity based on PCR or isothermal nucleic acid amplification.

    In addition, this team is continuing to research the primer for variant detection based on colorimetric buffer and isothermal nucleic acid amplification that can be stably quantified. And the team is conducting research with the goal to expand the technology beyond infection diagnosis to personal genome analysis system.

Medical Device Division

  • 01

    One-Step cartridge research

    The team is designing and developing the microfluidics control technology that can precisely adjust nucleic acid amplification and multi-chamber-based biochips. Moreover, this team is also conducting research & development on a one-step cartridge based on biochips that can simultaneously diagnose various pathogens by combining nucleic acid extraction technology.

  • 02

    Bio Sensor research

    The team is developing a sensor that can accurately measure the markers selected based on the technology that measures the minute changes of chemical markers appearing through nucleic acid amplification reaction. And through this research, the team is testing a more compact and easy-to-carry diagnostic device.

Bioinformatics Division

  • 01

    In silico-based diagnostic kit development & automation research

    The team is building a pipeline automatically designing the primer for precision diagnosis based on genome such as a primer for variation analysis and a primer capable of multiplexing from the basis of isothermal nucleic acid amplification using large amounts of primers. The team is making sure the kit is developed more accurately and promptly by analyzing the issues that may arise during the development of the diagnostic kit and developing in silico diagnostic analysis technology.

  • 02

    Diagnostic software and web development

    This team is developing an app and software for a diagnostic device that a user can use intuitively and easily, and is designing and developing a remote diagnostic platform through which an individual and a hospital can communicate with each other by using the results of personal self-diagnosis.